Amicus Therapeutics Inc (NASDAQ:FOLD)
| 8.98 BATS BZX Real-Time Price As of 12:49pm ET |  -0.29 / -3.13%Today’s Change | 7.11 Today|||52-Week Range 14.62 | -7.80% Year-to-Date |
Latest FOLD News | Press Releases
No recent news for Amicus Therapeutics Inc.
Today’s Trading
| Previous close | 9.27 |
| Today’s open | 9.42 |
| Day’s range | 8.80 - 9.42 |
| Volume | 878,635 |
| Average volume (3 months) | 3,488,559 |
| Market cap | $2.7B |
Data as of 12:49pm ET, 01/24/2020
Growth & Valuation
| Earnings growth (last year) | -1.54% |
| Earnings growth (this year) | +26.89% |
| Earnings growth (next 5 years) | +78.82% |
| Revenue growth (last year) | +147.08% |
| P/E ratio | NM |
| Price/Sales | 19.51 |
| Price/Book | 5.75 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| CCXIChemoCentryx Inc | +0.25 | +0.61% |
| ZGNXZogenix Inc | -1.84 | -3.39% |
| ---- | ||
| ARNAArena Pharmaceutical... | -1.03 | -2.25% |
Data as of 12:53pm ET, 01/24/2020
Financials
| Next reporting date | February 26, 2020 |
| EPS forecast (this quarter) | -$0.27 |
| Annual revenue (last year) | $91.2M |
| Annual profit (last year) | -$349.0M |
| Net profit margin | -382.48% |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Cranbury, New Jersey |
Forecasts
